Quantcast
Last updated on April 16, 2014 at 11:49 EDT

Latest Prenatal diagnosis Stories

2013-03-04 00:21:31

Over 100 Floridians, including patients treated while still in the womb, reunite with their Pennsylvania doctors and nurses CLEARWATER, Fla., March 3, 2013 /PRNewswire-USNewswire/ -- The Center for Fetal Diagnosis and Treatment at The Children's Hospital of Philadelphia (CHOP) today brought together a unique community of families from across Florida: all former CHOP patients who either underwent fetal surgery to treat conditions before birth, or needed specialized care or surgery...

2013-02-28 12:26:59

As one of the top four fetal cardiology programs in the country, center's multidisciplinary effort to save babies' hearts before birth brings families hope HOUSTON, Feb. 28, 2013 /PRNewswire-USNewswire/ -- The team at Texas Children's Fetal Center, one of the nation's leading centers for treating fetal anomalies, celebrates American Heart Month with an awareness campaign that encourages obstetricians and families to consider the need for specialized care when selecting a center to...

2013-02-20 08:29:17

MADISON, N.J. and SAN CARLOS, Calif., Feb. 20, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Natera, a leading innovator in prenatal genetic testing, today announced that Quest Diagnostics will offer physicians access to Panorama(TM), a new non-invasive prenatal test developed by Natera. Panorama uses cell-free fetal DNA in circulating maternal blood to screen for chromosomal abnormalities associated with trisomy 21...

2013-02-15 20:21:19

REDWOOD CITY, Calif., Feb. 15, 2013 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today presented data demonstrating its approach to detect aneuploidies in maternal blood from multiple gestation pregnancies. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) Contrary to previous study findings by other investigators, this study demonstrated that each fetus in twin pregnancies contributes approximately 50 percent less...

2013-02-12 08:29:16

--Specialists at The Children's Hospital of Philadelphia Describe Latest Advances in Fetal Diagnosis and Treatment-- PHILADELPHIA, Feb. 12, 2013 /PRNewswire-USNewswire/ -- Fetal surgery--including surgical interventions to repair birth defects in the womb­--is progressing into medical practice in highly specialized centers. Advanced imaging and diagnostic tools, new instruments and medications, and greater depth of experience are driving this rapidly evolving frontier of medicine....

2013-01-29 08:31:47

SAN JOSE, Calif., Jan. 29, 2013 /PRNewswire/ -- A study in the Journal of Maternal-Fetal and Neonatal Medicine highlights the cost-effectiveness of non-invasive prenatal testing (NIPT) with cell-free DNA (cfDNA) in high-risk women. NIPT was shown to have clinical benefit over conventional prenatal screening tests, and at a price point of $795, NIPT demonstrated cost savings to the healthcare system. (Logo: http://photos.prnewswire.com/prnh/20130129/SF49467LOGO) In the study, a...

2013-01-29 08:30:09

HOUSTON, Jan. 29, 2013 /PRNewswire-USNewswire/ -- Texas Children's Hospital and Baylor College of Medicine welcomed US-based and international obstetricians and gynecologists, radiologists, and sonographers to Houston for the Advances in Women's Healthcare Imaging Conference held on January 18-19. A primary objective of this conference was to review approaches in diagnostic imaging for women's health care and outline the most effective ways to integrate the information in to clinical...

2013-01-10 12:23:19

REDWOOD CITY, Calif., Jan. 10, 2013 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that its proprietary prenatal technology can detect fetal subchromosomal abnormalities non-invasively from maternal blood. These proof-of-concept data show that Verinata's proprietary approach together with deep massively parallel sequencing (MPS) is able to produce a non-invasive fetal karyotype equivalent to that provided by invasive...

2013-01-09 08:26:33

SAN JOSE, Calif., Jan. 9, 2013 /PRNewswire/ -- Ariosa Diagnostics is pleased to announce that they have entered into a mutual partnership with The Doctors Laboratory, in London, to promote and distribute the Harmony Prenatal Test. Under the terms of the agreement, TDL will offer the Harmony test through their reference laboratory services to doctors and their pregnant patients. (Logo: http://photos.prnewswire.com/prnh/20121203/NE22396LOGO ) (Logo:...

2013-01-09 08:26:32

SAN JOSE, Calif., Jan. 9, 2013 /PRNewswire/ -- Ariosa Diagnostics, provider of the Harmony(TM) Prenatal Test, today announced plans to expand the indications for the Harmony test and broaden access into new, significant global markets. (Logo: http://photos.prnewswire.com/prnh/20121203/NE22396LOGO ) The Harmony test analyzes cell-free DNA circulating in maternal blood, which allows a high level of accuracy for detecting fetal trisomies, such as trisomy 21 that causes Down syndrome....